LXRX Q1 2019 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-63.4% YoY

Gross Profit

$9M94.0% margin

Operating Income

-$17M-189.6% margin

Net Income

-$22M-236.5% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

-46.0%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$259M

Total Liabilities

$304M

Stockholders' Equity

-$46M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$25M	-63.4%
Gross Profit	$9M	$25M	-64.9%
Operating Income	-$17M	-$38M	+54.0%
Net Income	-$22M	-$42M	+48.2%